Advanced Enzyme Technologies Ltd

₹ 284 1.00%
02 Dec - close price
advancedenzymes.com BSE: 540025 NSE : ADVENZYMES
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Product Portfolio
The company manufactures and markets over 400+ proprietary products developed from over 70 enzymes and probiotics.[1]

Website BSE NSE
  • Market Cap ₹ 3,171 Cr.
  • Current Price ₹ 284
  • High / Low ₹ 359 / 257
  • Stock P/E 33.1
  • Book Value ₹ 104
  • Dividend Yield 0.35 %
  • ROCE 16.3 %
  • ROE 11.5 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Promoter holding has decreased over last quarter: -2.83%
  • The company has delivered a poor sales growth of 9.98% over past five years.
  • Dividend payout has been low at 7.14% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
111 112 110 110 120 138 133 137 127 134 132 121 139
64 59 62 59 62 71 78 74 78 85 91 90 99
Operating Profit 47 53 49 52 59 66 55 63 49 49 40 31 40
OPM % 42% 47% 44% 47% 49% 48% 41% 46% 39% 37% 31% 26% 29%
2 1 2 5 1 1 2 1 1 1 3 2 4
Interest 1 1 1 0 0 0 0 0 0 0 1 1 1
Depreciation 6 6 7 7 7 6 9 8 9 9 9 9 9
Profit before tax 42 47 43 50 52 61 48 55 41 41 34 24 34
Tax % 23% 26% 24% 30% 26% 27% 29% 27% 27% 31% 26% 26% 23%
Net Profit 32 35 33 35 39 44 34 40 30 29 25 18 26
EPS in Rs 2.77 3.01 2.81 3.07 3.33 3.86 2.81 3.40 2.66 2.46 2.19 1.60 2.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
116 171 219 239 222 293 329 391 420 444 502 529 525
93 109 130 189 131 155 177 226 236 241 269 327 365
Operating Profit 23 62 90 50 91 138 152 165 184 203 233 203 160
OPM % 20% 36% 41% 21% 41% 47% 46% 42% 44% 46% 46% 38% 30%
4 3 4 1 1 -3 3 1 5 6 9 6 10
Interest 3 12 10 13 9 8 4 9 5 4 3 3 2
Depreciation 5 6 8 10 9 9 13 18 21 26 29 35 35
Profit before tax 19 48 76 28 74 118 137 139 162 179 210 171 133
Tax % 10% 29% 34% 23% 31% 35% 32% 33% 28% 26% 28% 28%
Net Profit 17 34 50 21 51 77 93 94 116 133 151 124 98
EPS in Rs 1.62 3.22 4.52 1.85 4.60 6.97 8.20 8.07 9.95 11.58 13.06 10.70 8.59
Dividend Payout % 6% 1% 7% 6% 4% 3% 5% 6% 6% 5% 7% 9%
Compounded Sales Growth
10 Years: 12%
5 Years: 10%
3 Years: 8%
TTM: -2%
Compounded Profit Growth
10 Years: 14%
5 Years: 5%
3 Years: 2%
TTM: -33%
Stock Price CAGR
10 Years: %
5 Years: 0%
3 Years: 20%
1 Year: -15%
Return on Equity
10 Years: 18%
5 Years: 16%
3 Years: 15%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
21 21 22 22 22 22 22 22 22 22 22 22 22
Reserves 42 75 140 145 188 256 442 537 657 817 949 1,066 1,142
64 207 186 167 115 101 54 67 35 28 28 35 37
25 46 48 73 92 71 65 102 91 104 150 137 152
Total Liabilities 153 349 396 406 417 450 583 727 805 971 1,149 1,260 1,353
51 204 287 287 287 285 421 491 495 563 604 619 638
CWIP 19 60 2 2 5 7 8 11 10 10 10 15 16
Investments 0 0 0 0 0 0 0 0 111 124 121 102 234
82 84 107 117 125 158 153 226 188 275 414 524 465
Total Assets 153 349 396 406 417 450 583 727 805 971 1,149 1,260 1,353

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
16 49 41 43 54 93 107 116 129 141 163 122
-30 -187 -40 -25 -15 -10 -60 -60 -124 -43 -27 -19
27 128 -3 -20 -36 -63 -65 -2 -43 -39 -26 -27
Net Cash Flow 13 -10 -2 -1 2 21 -18 54 -38 60 109 75

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 70 70 65 49 61 52 55 55 51 61 63 61
Inventory Days 139 222 318 387 403 358 352 339 363 361 346 402
Days Payable 63 139 121 81 89 68 57 78 46 43 56 60
Cash Conversion Cycle 146 152 262 356 374 342 351 315 369 379 353 404
Working Capital Days 85 60 95 5 -4 40 106 82 90 100 104 122
ROCE % 28% 26% 12% 25% 37% 32% 26% 25% 23% 23% 16%

Shareholding Pattern

Numbers in percentages

7 recently
Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
57.86 57.88 58.13 55.45 55.39 55.38 52.30 52.55 52.71 52.70 52.70 49.88
10.96 11.12 11.02 16.01 17.11 16.79 16.40 16.27 16.39 18.01 18.72 21.68
8.68 8.89 8.69 6.32 6.28 7.32 8.46 8.66 8.99 6.90 6.26 5.60
22.50 22.11 22.16 22.23 21.22 20.51 22.84 22.52 21.91 22.38 22.32 22.86

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls